Sunovion Pharmaceuticals Inc. (formerly Sepracor) engages in discovering, developing, and commercializing therapeutic products for patients suffering from central nervous system disorders, respiratory disorders, and other illnesses. Its products include LUNESTA medicine that helps people sleep better; XOPENEX levalbuterol HCl inhalation solution; and BROVANA aformoterol tartrate inhalation solution. The company's products also comprise OMNARIS ciclesonide nasal spray; ALVESCO ciclesonide HFA inhalation aerosol; and LATUDA, an oral antipsychotic tablet for the treatment of schizophrenia. It offers products for the treatment of depression, epilepsy, neuropathic pain, and insomnia, as well as respiratory conditions, such as asthma, allergic rhinitis, and chronic obstructive pulmonary diseases.

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Esteve Química are committed to the Health Care Industry by supporting the development and commercialization of products that contribute to the better wellbeing of people. Their company was founded in 1966 within one of the largest Pharmaceutical Groups in Spain (Esteve). Ever since the beginning, they were able to implement an API manufacturing concept that gathers the best of the chemical and pharmaceutical worlds by using state-of-the-art technologies and installations, such as clean room areas for the last steps of manufacturing. Esteve Química has 50 years of experience developing, manufacturing and marketing oral and injectable-non-sterile APIs (NCEs and generics) for regulated markets. In addition to their generics business, they currently offer their API’s with a Finished Dosage File by establishing alliances with strategic pharmaceutical manufacturers and partners. Please find out more about how they can support you.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Jiangsu Tasly Diyi Pharmaceutical Co., Ltd., part of Tasly Pharmaceutical Group Co., Ltd., is a Chinese company located in Huai'An that manufactures and distributes pharmaceuticals. The firm was acquired by Tasly Pharmaceutical Group Co., Ltd. from Tianjin Fuhuade Science & Technology Development Co., Ltd. on March 30, 2013 for $233.33 million.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA.

Shanghai Shangyao Chinese and Western Pharmaceutical Co., Ltd., established on 1989-10-18, Business scope includes licensed projects:pharmaceutical production;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Engage in technology development in the field of pharmaceutical science and technology,technology transfer,technical consulting,Technical Services,Specialty Chemicals Sales(Free of Hazardous Chemicals).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ.

Endo Pharmaceuticals Solutions, Inc. develops products to treat conditions in urology and endocrinology. The company was founded in 2009 and is headquartered in Malvern, PA.

Tianjin Huajin Pharmaceutical Co. Ltd., a subsidiary of Jihua Group Corp. Ltd., is a Chinese company located in Tianjin that manufactures and distributes drugs.

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.

Sichuan Hongyuan Pharmaceutical Co., Ltd., established on 2007-06-06, Business scope includes licensed projects:pharmaceutical production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd., a subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd., is a Chinese company located in Shanghai that manufactures and distributes pharmaceutical products.

Lek Pharmaceuticals dd, a subsidiary of Novartis AG, is a company headquartered in Ljubljana, Slovenia, that develops, manufactures and markets drugs and pharmaceutical products. Robert Ljoljo is the CEO, in this role since 2019. On November 21, 2002 Novartis AG acquired Lek Pharmaceuticals dd for $689.24 million.

Generics (U.K.) Ltd. manufactures generic pharmaceutical products. It makes generic drugs which includes acid reflux remedy Pepcid, antibiotic Cipro and allergy treatment Zyrtec. The firm also manufactures cytotoxics such as azathioprine and penicillin based antibiotics. The company was founded on April 29, 1981 and is headquartered in Potters Bar, the United Kingdom.

Incorporated in 1994, Tasly Holding Group has now developed to an internationalized and high-tech cooperation, engaging in pan-health industry with biological medicine industry as the core business, health industry and medical service as two supporting businesses. Guided by Chinese ancient civilization, Tasly is devoted to the philosophy “seeking for harmonization between human and nature, improving humankind life quality” . With the mission of “to share the joy of health with all”, Tasly aims to become the No. 1 in modern biological pharmaceuticals and leader of integrated health industry in China. By now, Tasly has set up a pan-health industry line, which contains six core industries，including bio-pharmaceutical industry, health products industry, herbs industry, medical industry, health management industry and children education industry. Aiming to realize TCM globalization, Tasly has been sticking to develop the international market since its foundation. By now, more than 30 types of preparation products in 8 medical categories of Tasly have been put into the international market. And the export routes cover 23 countries in America, Europe, Africa and Asia. With the distribution network spreading to more than 40 countries, Tasly’s distributor members have almost reached a million in the world. In recent years, Tasly has been listed in the top 10 of TCM exporters in China. And in 2016, Tasly Pharm. Co.,Ltd was listed in the Top 500 of Chinese Enterprises released by the US Fortune magazine.